Objective Statin therapy is indicated in patients with peripheral arterial disease (PAD).
National Institute for Health and Care Excellence guidelines suggest the use of “high …

Background Hypertension is a major risk factor for peripheral artery disease (PAD). Little is
known about relative efficacy of antihypertensive treatments for preventing PAD. Objectives …

Aims Lower extremity peripheral artery disease (PAD) has been proposed as a 'coronary
heart disease (CHD) risk equivalent'. We aimed to examine whether PAD confers similar risk …

Patients with peripheral arterial disease (PAD) are at a markedly higher risk of
cardiovascular morbidity and mortality, with evidence indicating that risk-reduction …

Aim Risk factors for development of peripheral arterial disease (PAD) are the same as for
atherosclerotic coronary or precerebral disease, and patients with PAD have a high …

Peripheral arterial disease (PAD) of the lower limbs is the third most important site of
atherosclerotic disease alongside coronary heart disease (CHD) and cerebrovascular …

Peripheral arterial disease (PAD) is characterized by an impaired blood supply to the lower
extremities, and the prevalence of PAD increases with age. Patients with PAD show …

Atherosclerotic peripheral artery disease (PAD) is a growing health issue that affects more
than 200 million individuals worldwide, conferring a high risk of cardiovascular events and …

Peripheral artery disease (PAD) is a common condition with increasing prevalence in the
United States and worldwide (1, 2). Lower extremity involvement can be devastating for …

Background Patients with peripheral arterial disease (PAD) are at very high risk for
cardiovascular events. How do patients with PAD differ from age-and sex-matched controls …